The Wayback Machine - http://web.archive.org/web/20250205033229/https://finance.yahoo.com/sectors/healthcare/
Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
6.729T
Market Weight
9.85%
Industries
11
Companies
1210
Healthcare S&P 500 ^GSPC
Loading Chart for Healthcare
DELL

Day Return

Sector
0.03%
S&P 500
0.72%

YTD Return

Sector
6.55%
S&P 500
2.22%

1-Year Return

Sector
3.52%
S&P 500
21.77%

3-Year Return

Sector
6.69%
S&P 500
34.85%

5-Year Return

Sector
46.17%
S&P 500
81.06%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

IndustryMarket WeightYTD Return
All Industries
100.00%
6.55%
Drug Manufacturers - General
33.37%
4.21%
Medical Devices
13.58%
10.75%
Healthcare Plans
12.50%
9.33%
Biotechnology
10.91%
4.85%
Diagnostics & Research
10.84%
4.15%
Medical Instruments & Supplies
8.08%
7.25%
Medical Care Facilities
3.00%
11.18%
Drug Manufacturers - Specialty & Generic
2.65%
5.10%
Medical Distribution
2.53%
7.79%
Health Information Services
2.43%
14.96%
Pharmaceutical Retailers
0.13%
5.48%

Note: Percentage % data on heatmap indicates Day Return

Largest Companies in This Sector

View More
Table View
Heatmap View
Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
826.07 972.57 11.23% 742.898B +1.93% +7.00%
Buy
545.45 637.24 7.59% 501.969B -0.50% +7.83%
Strong Buy
153.49 168.64 5.59% 369.546B +1.07% +6.13%
Buy
189.95 204.90 5.07% 335.668B -0.10% +6.89%
Buy
90.74 123.63 3.47% 229.54B -9.07% -8.79%
Buy
129.10 133.08 3.39% 223.919B +0.51% +14.14%
Buy
580.57 662.36 3.36% 222.068B -2.22% +11.60%
Buy
579.65 629.37 3.12% 206.459B +0.19% +11.05%
Buy
289.02 315.85 2.35% 155.358B +0.05% +10.89%
Buy
215.01 268.88 2.35% 155.296B +0.35% -6.33%
Buy

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
147.04 36.396B 0.09% +6.88%
270.85 18.975B 0.10% +6.76%
138.81 6.463B 0.45% +4.99%
92.57 6.369B 0.35% +2.79%
64.17 4.4B 0.40% +9.97%

Mutual Fund Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
190.88 40.511B 0.30% +4.67%
80.48 40.511B 0.30% +4.67%
135.58 18.975B 0.10% +6.85%
84.55 13.014B 0.80% +6.07%
84.33 13.014B 0.80% +6.04%

Healthcare Research

View More

Discover the Latest Analyst and Technical Research for This Sector

  • Analyst Report: Merck & Co., Inc.

    Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

    Rating
    Price Target
     
  • Analyst Report: Pfizer Inc.

    Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

    Rating
    Price Target
     
  • Analyst Report: Coloplast A/S

    Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

    Rating
    Price Target
     
  • Analyst Report: McKesson Corporation

    McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

    Rating
    Price Target
     

From the Community

Healthcare News